Jan 1, 1980

Plasma levels of protease inhibitors in acute myeloid leukemia at the onset of the disease and during antiblastic therapy

Thrombosis Research
G GambaE Ascari


No abstract listed.

  • References13
  • Citations2


  • References13
  • Citations2

Mentioned in this Paper

Disseminated Intravascular Coagulation
Acute Myeloid Leukemia, M1
Protease Inhibitors
Blood Coagulation Tests

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.